Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05161169Not ApplicableCompleted

Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants

Role: collaborator

NCT07146412Not ApplicableRecruiting

Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study

Role: lead

NCT03842995Not ApplicableCompleted

South-seq: Deoxyribonucleic Acid (DNA) Sequencing for Newborn Nurseries in the South

Role: collaborator

NCT02795013Completed

Genetic Study of Families With High Frequency of Hodgkin Lymphoma

Role: collaborator

All 4 trials loaded